Evolent Health, Inc. Balance Sheet
EVH|11 years of annual SEC 10-K data (FY2015-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 11 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$1.9B
FY2025
Cash
$152M
Cash and equivalents
Total Debt
$971M
FY2025
Shareholder Equity
$415M
FY2025
Evolent Health, Inc. had $1.9B in total assets and $415M in shareholders' equity as of FY2025. Total debt was $971M against $152M in cash, resulting in $819M net debt.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.84 (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
- Negative return on equity: -15.6% ROE
- High leverage: Debt-to-equity ratio of 2.34
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $151.9M | $104.2M | $192.8M | $188.2M | $266.3M | $319.0M | $101.0M | $228.3M | $238.4M | $134.6M | $145.7M |
| Accounts Receivable | $309.9M | $414.7M | $446.7M | $254.7M | $130.6M | $124.1M | $75.7M | $80.2M | $48.9M | $40.6M | $20.4M |
| Current Assets | $506.4M | $607.1M | $683.7M | $478.1M | $524.0M | $547.6M | $228.8M | $488.0M | $378.2M | $265.0M | $184.5M |
| PP&E (Net) | $80.8M | $73.2M | $78.2M | $87.9M | $81.4M | $86.2M | $85.2M | $73.6M | $50.9M | $31.2M | $0 |
| Goodwill | $694.5M | $1.1B | $1.1B | $722.8M | $426.3M | $349.0M | $566.4M | $768.1M | $628.2M | $626.6M | $608.9M |
| Total Assets | $1.9B | $2.5B | $2.7B | $1.8B | $1.4B | $1.4B | $1.5B | $1.7B | $1.3B | $1.2B | $1.0B |
| Current Liabilities | $385.3M | $715.5M | $674.2M | $433.4M | $445.5M | $403.3M | $192.8M | $269.4M | $132.7M | $131.9M | $59.5M |
| Total Debt | $970.5M | $490.5M | $597.0M | $413.0M | $215.7M | $263.3M | $293.7M | $221.0M | $121.4M | $120.3M | $0 |
| Shareholders' Equity | $415.2M | $1.0B | $1.1B | $859.4M | $693.6M | $619.6M | $929.0M | $1.1B | $1.0B | $702.5M | $649.3M |